Literature DB >> 1829511

Docosahexaenoic acid (cervonic acid) incorporation into different brain regions in the awake rat.

N Sarda1, A Gharib, P Moliere, E Grange, P Bobillier, M Lagarde.   

Abstract

A quantitative method is presented to examine the localization, in individual brain regions of awake rats, of docosahexaenoic acid (22:6 n-3 or cervonic acid), the main polyunsaturated fatty acid of the nervous system together with arachidonic acid. Following the intravenous injection of 10 microCi [14C]22:6 n-3 (around 0.2 mumol/rat). 0.11-0.28% of the initial radioactivity was located in specific brain areas after detection from 10 to 240 min. Brain regional radioactivity determined by quantitative autoradiography indicated that 60 min after injection, [14C]22:6 n-3 concentrations ranged from 13.75 nCi/g of tissue in inferior olive to 5.59 nCi/g in frontal cortex. The results indicate a higher incorporation into the auditory system: inferior colliculus, central cochlear nucleus, lateral lemniscus, into neuroendocrine structures: paraventricular and supraoptic nuclei, and into certain circumventricular organs such as the pineal gland and neurohypophysis. Analysis of the Bligh and Dyer lipid extracts of rat brain revealed that 60 min after injection, 80-85% of the radioactivity was in choline and ethanolamine phosphoglycerides. These observations suggest that intravenous injection of [14C]22:6 n-3 may be used to study the brain lipid compartmental metabolism in vivo in order to visualize alterations of structural lipid components.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829511     DOI: 10.1016/0304-3940(91)90157-o

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Authors:  R J Wurtman; M Cansev; I H Ulus
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

2.  Reduced auditory acuity in rat pups from excess and deficient omega-3 fatty acid consumption by the mother.

Authors:  Michael W Church; K-L Catherine Jen; Tina Stafferton; John W Hotra; Brittany R Adams
Journal:  Neurotoxicol Teratol       Date:  2006-11-01       Impact factor: 3.763

3.  Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid.

Authors:  Mayssa Hachem; Alain Géloën; Amanda Lo Van; Baptiste Foumaux; Laurence Fenart; Fabien Gosselet; Pedro Da Silva; Gildas Breton; Michel Lagarde; Madeleine Picq; Nathalie Bernoud-Hubac
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

4.  Docosahexaenoic acid therapy in docosahexaenoic acid-deficient patients with disorders of peroxisomal biogenesis.

Authors:  M Martinez
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 5.  Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications.

Authors:  M Martinez
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells.

Authors:  A Petroni; M Salami; M Blasevich; N Papini; C Galli
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

Review 7.  Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.

Authors:  Mehmet Cansev; Richard J Wurtman; Toshimasa Sakamoto; Ismail H Ulus
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

8.  Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils.

Authors:  M Cansev; R J Wurtman
Journal:  Neuroscience       Date:  2007-08-01       Impact factor: 3.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.